| Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans M Grazia Roncarolo, S Gregori, M Battaglia, R Bacchetta, K Fleischhauer, ... Immunological reviews 212 (1), 28-50, 2006 | 1590 | 2006 |
| Type 1 T regulatory cells MG Roncarolo, R Bacchetta, C Bordignon, S Narula, MK Levings Immunological reviews 182 (1), 68-79, 2001 | 1165 | 2001 |
| Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells N Gagliani, CF Magnani, S Huber, ME Gianolini, M Pala, P Licona-Limon, ... Nature medicine 19 (6), 739-746, 2013 | 882 | 2013 |
| Regulatory T cells induced by 1α, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance S Gregori, M Casorati, S Amuchastegui, S Smiroldo, AM Davalli, L Adorini The Journal of Immunology 167 (4), 1945-1953, 2001 | 820 | 2001 |
| A 1α, 25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice S Gregori, N Giarratana, S Smiroldo, M Uskokovic, L Adorini Diabetes 51 (5), 1367-1374, 2002 | 709 | 2002 |
| Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+ CD4+ Tr cells MK Levings, S Gregori, E Tresoldi, S Cazzaniga, C Bonini, MG Roncarolo Blood 105 (3), 1162-1169, 2005 | 659 | 2005 |
| Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10–dependent ILT4/HLA-G pathway S Gregori, D Tomasoni, V Pacciani, M Scirpoli, M Battaglia, CF Magnani, ... Blood, The Journal of the American Society of Hematology 116 (6), 935-944, 2010 | 613 | 2010 |
| Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. S Trembleau, G Penna, E Bosi, A Mortara, MK Gately, L Adorini The Journal of experimental medicine 181 (2), 817-821, 1995 | 554 | 1995 |
| Tr1 cells: from discovery to their clinical application M Battaglia, S Gregori, R Bacchetta, MG Roncarolo Seminars in immunology 18 (2), 120-127, 2006 | 358 | 2006 |
| CD4+ T‐regulatory cells: toward therapy for human diseases SE Allan, R Broady, S Gregori, ME Himmel, N Locke, MG Roncarolo, ... Immunological reviews 223 (1), 391-421, 2008 | 307 | 2008 |
| Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development S Gregori, N Giarratana, S Smiroldo, L Adorini The Journal of Immunology 171 (8), 4040-4047, 2003 | 288 | 2003 |
| CD4+ regulatory T cells: mechanisms of induction and effector function R Bacchetta, S Gregori, MG Roncarolo Autoimmunity reviews 4 (8), 491-496, 2005 | 277 | 2005 |
| Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance M Battaglia, A Stabilini, E Draghici, S Gregori, C Mocchetti, E Bonifacio, ... Diabetes 55 (1), 40-49, 2006 | 276 | 2006 |
| The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases MG Roncarolo, S Gregori, R Bacchetta, M Battaglia, N Gagliani Immunity 49 (6), 1004-1019, 2018 | 274 | 2018 |
| Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications MG Roncarolo, S Gregori, R Bacchetta, M Battaglia Interleukin-10 in Health and Disease, 39-68, 2014 | 269 | 2014 |
| Is FOXP3 a bona fide marker for human regulatory T cells? MG Roncarolo, S Gregori European journal of immunology 38 (4), 925-927, 2008 | 223 | 2008 |
| Induction of tolerance in type 1 diabetes via both CD4+ CD25+ T regulatory cells and T regulatory type 1 cells M Battaglia, A Stabilini, E Draghici, B Migliavacca, S Gregori, E Bonifacio, ... Diabetes 55 (6), 1571-1580, 2006 | 212 | 2006 |
| Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell–mediated effects on regulatory T cells E Hauben, S Gregori, E Draghici, B Migliavacca, S Olivieri, ... Blood, The Journal of the American Society of Hematology 112 (4), 1214-1222, 2008 | 202 | 2008 |
| Understanding autoimmune diabetes: insights from mouse models L Adorini, S Gregori, LC Harrison Trends in molecular medicine 8 (1), 31-38, 2002 | 183 | 2002 |
| Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells CF Magnani, G Alberigo, R Bacchetta, G Serafini, M Andreani, ... European journal of immunology 41 (6), 1652-1662, 2011 | 179 | 2011 |
Megan K. LevingsUniversity of British ColumbiaVerified email at ubc.ca
